• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    T. Rowe Price Group Inc. filed SEC Form 8-K: Other Events

    12/5/24 7:24:09 AM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance
    Get the next $TROW alert in real time by email
    trow-20241204
    0001113169falsePRICE T ROWE GROUP INC00011131692024-12-042024-12-04

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    ___________________________

    FORM 8-K

    CURRENT REPORT
    Pursuant to Section 13 of the Securities Exchange Act of 1934


    Date of Report (Date of earliest event reported): December 4, 2024

    T. Rowe Price Group, Inc.
    (Exact name of registrant as specified in its charter)
    Maryland000-3219152-2264646
    (State of
    incorporation)
    (Commission
    File Number)
    (IRS Employer
    Identification No.)
    100 East Pratt Street, Baltimore, Maryland 21202
    (Address of principal executive offices)(Zip Code)

    Registrant's telephone number, including area code: (410) 345-2000

    N/A
    (Former Name of Former Address, if Changed Since Last Report)

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

    ☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    ☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    ☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

    ☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading SymbolName of each exchange on which registered
    Common Stock, par value $0.20TROW
    The NASDAQ Stock Market LLC
    (Nasdaq Global Select Market)

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12-2 of this chapter).
                                            Emerging growth company ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐




    Section 8 - OTHER EVENTS

    Item 8.01. Other Events.

    On December 4, 2024, the Board of Directors of T. Rowe Price Group, Inc. (the “Company”), approved a 15 million share increase in the Company’s authorization to repurchase shares of its common stock. Following this increase, as of December 4, 2024, the total repurchase authorization will be approximately 19 million shares of the Company’s outstanding common stock. Repurchases may be effected from time to time on the open market or in privately negotiated transactions, or in such other manner as determined by the Company including through plans complying with Rule 10b5-1 under the Exchange Act, based on a variety of factors such as price, corporate requirements, and overall market conditions. There can be no assurance as to the number of shares the Company will purchase, if any. The share repurchase program may be increased or otherwise modified, renewed, suspended, or terminated by the Company at any time, without prior notice. The share repurchase program does not have an expiration date.


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
    T. Rowe Price Group, Inc.
    By: /s/ David Oestreicher
    Vice President, General Counsel and Secretary
    Date: December 5, 2024

    Get the next $TROW alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $TROW

    DatePrice TargetRatingAnalyst
    9/12/2024$109.00Equal Weight
    Wells Fargo
    8/27/2024$99.00Underweight
    Barclays
    4/11/2024$106.00 → $120.00Underperform → Mkt Perform
    Keefe Bruyette
    4/8/2024$92.00 → $114.00Sell → Hold
    TD Cowen
    1/8/2024$95.00 → $105.00Equal Weight → Underweight
    Wells Fargo
    1/4/2024$88.00Underperform
    TD Cowen
    10/31/2023$100.00 → $95.00Sell → Neutral
    Citigroup
    5/19/2023$98.00Sell
    Citigroup
    More analyst ratings

    $TROW
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • OHA is Administrative Agent and Lead Left Arranger of Private Debt Financing Supporting Montagu's Acquisition of Tyber Medical

      New York, New York, June 18, 2025 (GLOBE NEWSWIRE) -- Oak Hill Advisors ("OHA") served as Administrative Agent and Lead Left Arranger for the private senior debt financing supporting the acquisition of Tyber Medical, LLC ("Tyber Medical") by Montagu Private Equity ("Montagu"). Tyber Medical is a leading orthopedic device manufacturer serving the spine and trauma end markets. As part of the transaction, Montagu will merge Tyber Medical with two of its existing portfolio companies, Resolve Surgical Technologies ("Resolve") and Intech Medical ("Intech"), to create a scaled contract development and manufacturing organization ("CDMO") offering end-to-end services that span product conceptua

      6/18/25 8:00:00 AM ET
      $TROW
      Investment Bankers/Brokers/Service
      Finance
    • T. ROWE PRICE ADDS THREE NEW TRANSPARENT SECTOR OFFERINGS TO ITS ACTIVE ETF ROSTER

      The T. Rowe Price Financials ETF, Health Care ETF and Natural Resources ETF began trading today and expanded the firm's ETF lineup to 22 BALTIMORE, June 12, 2025 /PRNewswire/ -- T. Rowe Price (NASDAQ-GS: TROW), a global investment management firm, announced today the addition of three new active transparent equity exchange-traded funds (ETF): T. Rowe Price Financials ETF (Ticker: TFNS), T. Rowe Price Health Care ETF (Ticker: TMED), and T. Rowe Price Natural Resources ETF (Ticker: TURF). The new funds began trading on NASDAQ today. T. Rowe Price's active ETF roster now sits at 22 offerings.

      6/12/25 10:05:00 AM ET
      $TROW
      Investment Bankers/Brokers/Service
      Finance
    • T. ROWE PRICE RELEASES 2025 MIDYEAR INVESTMENT OUTLOOK

      Investing in a post-globalization world with reconfigured global trade necessitates a careful assessment of market opportunities and risks BALTIMORE, June 9, 2025 /PRNewswire/ -- T. Rowe Price, a global investment management firm and a leader in retirement, released its midyear outlook for global financial markets for the remainder of 2025. Underpinning the outlook for the next six months is an accelerated trend toward deglobalization, a tariff-driven reconfiguration of global trade, an expected broadening of stock market opportunities globally beyond U.S. equities and mega-cap tech stocks, and a bond market regime change driven by trade policy changes and German fiscal expansion.

      6/9/25 1:00:00 PM ET
      $TROW
      Investment Bankers/Brokers/Service
      Finance

    $TROW
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Wells Fargo initiated coverage on T. Rowe Price with a new price target

      Wells Fargo initiated coverage of T. Rowe Price with a rating of Equal Weight and set a new price target of $109.00

      9/12/24 9:14:34 AM ET
      $TROW
      Investment Bankers/Brokers/Service
      Finance
    • Barclays initiated coverage on T. Rowe Price with a new price target

      Barclays initiated coverage of T. Rowe Price with a rating of Underweight and set a new price target of $99.00

      8/27/24 7:37:56 AM ET
      $TROW
      Investment Bankers/Brokers/Service
      Finance
    • T. Rowe Price upgraded by Keefe Bruyette with a new price target

      Keefe Bruyette upgraded T. Rowe Price from Underperform to Mkt Perform and set a new price target of $120.00 from $106.00 previously

      4/11/24 8:03:23 AM ET
      $TROW
      Investment Bankers/Brokers/Service
      Finance